Allianz SE VNA O.N. Stock Timeline

2026-08-07 — Q2 2026 / H1 2026 results; dividend and buyback progress

Allianz reported record H1 2026 operating profit of EUR 9.4bn, up 9% year-over-year, with strong core earnings per share. Management reaffirmed full-year operating profit guidance of EUR 17.4bn ± EUR 1bn. The company completed EUR 1.8bn of its EUR 2.5bn buyback program by end-July and maintained a very strong Solvency II ratio around 225%. The 2025 dividend was set at EUR 17.10 per share and paid in May 2026 [1][14][3].

Market perception shifted toward viewing Allianz as a quality, capital-rich compounder executing disciplined capital returns. Investors emphasized capital strength, reliable dividend growth and buybacks as core return drivers while treating insurance underwriting cycles and market yields as key earnings levers [11][14].

Price action showed a strong rally and breakout on confirmation of record results and buyback progress. The chart characterized resumed uptrend and reduced volatility as capital returns reassured investors [1][14].

2026 (June–Aug) — Share price reference and investor context

Current market pricing reflects continued execution on capital returns following H1 results, with dividend paid and buyback progressing toward target [3][user-provided fact].

Investors treated the stock as a high-yield, cash-returning blue-chip insurance name with lower perceived tail risk given elevated solvency and ongoing buybacks [1][14]. Momentum investors reacted to the EPS beat while income investors focused on yield and payout ratio consistency.

The stock consolidated at elevated levels after the H1 rally. Range-building appeared likely as the market digested gains, though the overall uptrend remained intact [14][user-provided fact].

2025 (full year / FY 2025 results and capital actions)

Allianz executed and expanded share buybacks with a new EUR 2.0bn program announced February 27, 2025; approximately EUR 1.0bn was repurchased by mid-2025. Management maintained dividend policy, reiterated multi-year targets and planned cancellation of repurchased shares. Capital allocation emphasized the combined buyback and dividend approach [24][16][21].

The market perceived Allianz as a disciplined capital allocator leaning into buybacks to offset slower organic growth and lift earnings per share. The narrative shifted from a pure dividend story to a combined dividend plus buyback total-return story, supported by creditworthiness and Solvency metrics [24][20].

The stock sustained an uptrend through 2025 driven by buyback news and improved operating metrics, punctuated by short consolidations after program announcements as markets priced in share reduction effects [20][24].

2024 — Strong operating performance, buybacks and portfolio moves

FY 2024 operating profit reached record levels. Allianz announced an operating profit guidance uplift and proposed a higher dividend of EUR 15.40 per share for 2024. The Board authorized buybacks up to 10% of share capital through 2029, with approximately EUR 1.5bn executed during 2024 across programs. The company completed the sale of Euler Hermes Re S.A. on June 20, 2024, as part of restructuring in Global Insurance Lines [21][10][16].

The market shifted to a "value unlocking plus return of capital" view. Improved underwriting and life/health performance combined with disposals and buybacks made the company a more attractive dividend and growth mix. Some investors noted reliance on buybacks for earnings per share accretion but accepted this given strong solvency [21][10].

Price action showed a breakout and multi-month rally as results surprised to the upside and buyback scale became clear. Mid-2024 pullbacks around operational news gave way to higher lows forming a structural uptrend [21][16].

2023 — Operating resilience, higher payout ratio, natural catastrophe headwinds

FY 2023 operating profit improved to approximately EUR 14.7bn, and shareholders' core net income increased materially. Management raised the payout ratio to 60% and proposed a dividend of EUR 13.80 for 2023. Property-casualty faced higher natural catastrophe claims, but life/health and asset management offset much of the pressure [27].

The market saw Allianz as resilient through catastrophes, reassured by diversified earnings and asset management tailwinds. Raising the payout ratio signaled management confidence in capital and earnings quality, moving perception toward durable income with selective growth [27].

Price action recovered from earlier-year drawdowns as cat losses were priced in, then moved into a steady uptrend as dividend and diversified earnings reduced the risk premium [27].

2022 — Post-pandemic normalization and strategic focus

Allianz navigated post-COVID market normalization with underlying insurance pricing strength in property and casualty lines. The company maintained continued focus on margin recovery in Life & Health and asset management growth. Share buyback authorizations and selective M&A and partnership activity continued through Board resolutions [annual reports 2022/2023 reflected in later filings][16].

Investors viewed Allianz as executing on a multi-year strategic plan of margin improvement, digital initiatives and selective disposals. Sentiment gradually turned constructive as underwriting cycles improved and asset management fees grew, though the market remained watchful for macro interest-rate and inflation effects on reserves and yields.

The chart showed a multi-quarter range gradually shifting into uptrend as structural improvements were slowly priced in, with volatile episodes when macro or claims news arrived.

2021 — Pandemic aftermath, capital preservation and dividend normalization

Post-2020 pandemic effects continued through 2021 results with COVID-related reserve releases in parts of the business and lower investment yields ahead of later rate rises. Management maintained dividends and reiterated capital priorities. Strategy execution in digital and customer segmentation accelerated [Allianz annual disclosures 2021/2022 summarized in later IR materials].

The market treated Allianz as a large, defensive insurance compounder recovering from pandemic earnings noise. Dividend reliability remained central, though investors awaited clearer evidence of sustained profit growth beyond one-off pandemic effects.

Price action recovered from 2020 lows into a multi-year base and range through 2021–2022 as technical consolidation proceeded while fundamentals stabilized and the stock awaited clearer earnings expansion.